当前位置:首页 - 行情中心 - 泓博医药(301230) - 财务分析 - 利润表

泓博医药

(301230)

  

流通市值:9.99亿  总市值:46.72亿
流通股本:1642.81万   总股本:7687.33万

利润表

按照会计年度查询:
报告期2022-09-302022-06-302021-12-312021-06-30
一、营业总收入332,128,900.74205,867,164.68448,213,754.22189,434,178.77
营业收入332,128,900.74205,867,164.68448,213,754.22189,434,178.77
二、营业总成本290,735,543.04182,151,376.73361,321,684.82159,281,792.42
营业成本212,123,679.12128,079,315.86274,810,156.67122,266,431.85
营业税金及附加1,250,925.54774,286.021,767,353.231,055,308.61
销售费用5,023,159.42,699,683.565,242,176.572,339,241.86
管理费用56,941,089.6840,735,37357,749,872.7726,912,414.49
财务费用-7,049,305.89-4,107,082.24,607,728.381,176,148.92
资产减值损失-1,600,196.84-2,093,051.26-2,060,998.24-2,261,261.71
三、其他经营收益19,924.8331,496.5236,211.23-51,608.39
允许价值变动净收益-160,464.59-246,758.49397,682.96437,621.7
投资净收益599,615.91471,449.811,801,778.62-817.85
联营、合营企业投资收益--732.01-1,621.38-817.85
汇兑净收益--------
四、营业利润42,018,520.5423,273,435.4286,664,651.2226,813,958.77
营业外收入205,669.6780,88356,885.8218,600
营业外支出73,878.3654,319.69488,793.7592,729.54
非流动资产处置净损失--------
五、利润总额42,150,311.8523,299,998.7386,232,743.2926,739,829.23
所得税3,977,030.132,778,579.0712,656,126.044,262,749.2
未确认的投资损失--------
六、净利润(百万元)38.1720.5273.5822.48
少数股东损益--------
归属于母公司股东的净利润38,173,281.7220,521,419.6673,576,617.2522,477,080.03
七、每股收益0.660.361.280.39
基本每股收益0.660.361.280.39
稀释每股收益0.660.361.280.39
TOP↑